Blood donor centres can effectively publicise cancer screening

Public Health

Volumn 110, Issue 4, 1996, Pages 247-249

  Hart, A R ^a   Jestico, B ^b   Antill, C ^c   Taylor, M ^a   Mayberry, J F ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c Leicester Blood Transfusion Service   (United Kingdom)

Author keywords

Blood Transfusion Service; Colorectal carcinoma; Faecal occult blood tests; Screening

Indexed keywords

ADULT; ADVERTIZING; ARTICLE; BLOOD DONOR; CANCER SCREENING; COLORECTAL CANCER; FEMALE; HEALTH CENTER; HEALTH PROMOTION; HUMAN; MALE; NORMAL HUMAN; OCCULT BLOOD; UNITED KINGDOM;

EID: 0029776879     PISSN: 00333506     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3506(96)80111-9     Document Type: Article

References (19)

1. Thomas WM, Hardcastle JD. An update on the Nottingham trial of faecal occult blood screening for colorectal carcinoma. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC, (eds). Cancer screening. Cambridge University Press: Cambridge, England, 1991, 106-115.
2. Kronborg O et al. Initial mass screening for colorectal cancer with faecal occult blood test. Scand. J. Gastroenterol 1987; 22: 677-686.
3. Kewenter J et al. A randomised trial of faecal occult blood testing for early detection of colorectal cancer. Results of screening and rescreening of 51,325 subjects. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC, (eds) Cancer screening. Cambridge University Press: Cambridge, England, 1991: 116-125.
4. Winnawer SJ, Schottenfeld D, Flehinger BJ. Colorectal cancer screening. J Nat Cancer Inst 1991; 83: 243-253.
5. Mandel JS et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Eng J Med 1993; 328: 1365-1371.
6. Hobbs FDR et al. Acceptability of opportunistic screening for occult gastrointestinal blood loss. BMJ 1992; 304: 483-486.
7. Nichols S et al. Randomised trial of compliance with screening for colorectal cancer. BMJ 1986; 293: 107-110.
8. Merk K et al. The incidence of cancer among blood donors. Int J Epidemiol 1990; 19: 505-509.
9. Farrands PA, Hardcastle JD, Chamberlain J, Moss S. Factors affecting compliance with screening for colorectal cancer. Commun Med 1984; 6: 12-19.
10. Spector MH et al. Assessment of attitudes towards mass screening for colorectal cancer and polyps. Prev Med 1981; 10: 105-109.
11. Silman A, Mitchell P. Attitudes of non-participants in an occupational based screening programme for colorectal cancer. Commun Med 1984; 6: 8-11.
12. Hynam KA et al. Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in general practice in England. J Epidemiol & Commun Health 1995; 49: 84-86.
13. Hart AR et al. Screening for colorectal cancer in Market Harborough, UK. A community based programme. Eur J Gastroenterol & Hepatol 1994; 6: 519-522.
14. Farrands PA, Griffiths RL, Britton DC. The Frome Experiment-Value of screening for colorectal cancer. Lancet 1981; i: 1231-1232.
15. Lallemand RC, Vakil PA, Pearson P, Box V. Screening for asymptomatic bowel cancer in general practice. BMJ 1984; 288: 31-33.
16. Office of Population Censuses and Surveys. Mortality statistics 1985. Series DH2.12 HM Stationery Office: London, 1987.
17. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-2270.
18. Stryker SJ et al. Natural history of untreated colonic polyps. Gastroenterology 1987; 93: 1009-1013.
19. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Eng J Med 1992; 326: 658-662.